In partnership with medtech company Abbott, Simulands, a global leader in medical simulation technology and innovative training solutions, announces the opening of this groundbreaking facility. This state-of-the-art centre in Eschborn, Germany, sets new standards in medical education by placing physicians, students and their learning experience at the forefront of its concept. The centre represents a […]

Hamburg / Tübingen / Dresden, 15 January 2025 The Healthcare Specialists GENUI and SHS Capital are jointly investing in ROTOP, a leading European manufacturer and CDMO for radiopharmaceuticals. ROTOP Pharmaka GmbH, founded in 2000 and based in Dresden-Rossendorf, is a leading supplier of radiopharmaceutical products. Radioactive pharmaceuticals are increasingly being used, both for diagnostic applications […]

Tübingen / 26 November 2024 SHS Capital acquires a majority stake in the therapy and rehabilitation home care provider MTR. The aim of the investment is to further grow the core business and support the nationwide expansion that has already been initiated. Medizintechnik Rostock GmbH is a home care provider for therapy devices, founded in […]

Meet our SHS Capital colleagues Sascha Alilovic, Dr. Cornelius Maas and Georg Helg at the MEDICA from 11 to 14 November in Düsseldorf. MEDICA is one of the largest medical B2B trade fairs in the world. For over 40 years, it has been a fixed date in the calendar of all experts. Please feel free […]

Since SHS became a member of the UN PRI and even before that, we have endeavoured to comply with ESG guidelines both within our own company and at all our portfolio companies. Existing portfolio companies are regularly subjected to an ESG review. A dedicated ESG review is also carried out for potential new portfolio companies […]

In a mini-series, SHS discussed how buy-and-build strategies can be developed and implemented in the healthcare sector with its portfolio companies as part of its portfolio workshops and internally with its colleagues as part of the SHS Academy.The workshops were supported by Valerie Rinecker, Managing Director of Altenried Etti & Co, an investment banking boutique […]

Verena Schiller has been appointed as the new Chief Executive Officer of Tyromotion GmbH. She brings global sector expertise and twenty years of experience in medical technology, particularly in the field of neurosurgery and radiotherapy. In previous roles, her focus was strongly on sales and internationalisation – one of the core growth drivers for Tyromotion […]

The Swiss SHS portfolio company TRI Dental Implants has successfully entered the US market as a direct market. This step enables the company bring its pioneering digital dental solutions directly to American customers. With a dedicated local team, important partnerships have been established and the sales structure has been successfully set up. This marks another […]

CoreMedic has appointed a new Chairwoman of the Board for the company. Jodi Akin is a healthcare leader and innovator. She has more than 25 years of experience in clinical development, scientific and regulatory strategy, and the management and development of the medical device market. With her impressive track record, she will bring critical expertise […]

SHS portfolio company Simulands, based in Zurich, has unveiled a ground-breaking portable and ultra-lightweight medical simulator simuGO, designed to enhance product demonstrations in the cardiology field. This innovative device, which can be set up in just 20 seconds, enables on-the-go and in-office demonstrations, significantly improving engagement and understanding of innovative and complex cardiology medical technology […]

Thomas Kraft has been appointed as the new Chief Executive Officer of SIS Medical AG. He has held this position since the beginning of September. Mr Kraft has over 20 years of global experience in the MedTech sector and brings a track record of strategic growth and operational excellence to SIS Medical. His background uniquely […]

Tuebingen / 07.10.2024 SHS Capital is pleased to announce a significant investment alongside its limited partners in one of its portfolio companies, Develco. SHS Capital has been a committed investor since 2020 and is pleased to have offered its LPs the opportunity to co-invest in Develco. Develco is a specialty pharma company focused on the […]